Yohimbine: behavioral and biochemical effects in mice.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001831:Body Temperature / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010293:Pargyline / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors; D015016:Yohimbine / Q000494:pharmacology*
D002395:Catecholamines; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D015016:Yohimbine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D012110:Reserpine; D010293:Pargyline; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D007490:Iproniazid; D010134:Fenclonine; D008784:Methysergide